Cost-Savings/ Reimbursement

Research Category:Accelerated Wound Healing

Routine Fluorescence Imaging to Detect Wound Bacteria Reduces Antibiotic Use and Antimicrobial Dressing Expenditure While Improving Healing Rates: Retrospective Analysis of 229 Foot Ulcers

Diagnostics 2020, 10(11), 927

Download Publication

Research Category:Cost-Savings/ Reimbursement

Can Fluorescence Imaging Predict the Success of CTPs (cellular- and tissue-based products) for Wound Closure and Save Costs?

Today’s Wound Clinic, Volume 13 Issue 12 - December 2019

Download Publication

Research Category:Treatment Planning

Fluorescence imaging guided dressing change frequency during negative pressure wound therapy: a case series

Journal of Wound Care, September (2019)

Download Publication

Research Category:Burns

The utility of MolecuLight bacterial sensing in the management of burns and traumatic wounds

Proc. SPIE 10863, Photonic Diagnosis and Treatment of Infections and Inflammatory Diseases II, 1086304 (7 March 2019); doi: 10.1117/12.2504377

Download Publication

Find out how to make a difference in wound care

MolecuLight Headquarters

425 University Avenue
Suite 700
Toronto, ON M5G 1T6
Canada

US Address
MolecuLight Corp.
2403 Sidney Street,
Suite 209
Pittsburgh, PA 15203

T. +1 647-362-4684
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com

MolecuLight is SOC ll^®
Type l Accredited:

MolecuLight awarded
Premier’s Technology
Breakthrough Designation

MolecuLight i:X
is designated as a:

MolecuLight included
in ISWCAP Consensus
Guidelines:

MolecuLight is a proud
corporate member of:

Global

USA

©2023
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.